[Adverse events after administration of A/H1N1 vaccine to patients].
Hernández-García
Ignacio
I
Haro-Pérez
Ana María
AM
González-Celador
Rafael
R
Sáenz-González
María Del Carmen
Mdel C
D000276:Adjuvants, Immunologic / Q000009:adverse effects; D000293:Adolescent; D000328:Adult; D000368:Aged; D015331:Cohort Studies; D005334:Fever / Q000453:epidemiology / Q000209:etiology*; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000276:immunology*; D007252:Influenza Vaccines / Q000009:adverse effects*; D008875:Middle Aged; D010146:Pain / Q000453:epidemiology / Q000209:etiology*; D011136:Polysorbates / Q000009:adverse effects; D013030:Spain / Q000453:epidemiology; D013185:Squalene / Q000009:adverse effects; D014611:Vaccination; D015164:Vaccines, Inactivated / Q000009:adverse effects; D055815:Young Adult
D000276:Adjuvants, Immunologic; D007252:Influenza Vaccines; C089950:MF59 oil emulsion; D011136:Polysorbates; D015164:Vaccines, Inactivated; D013185:Squalene